| Business Summary | | Biomerica,
Inc.
is
primarily
engaged
in
the
following
activities:
the
development,
manufacture
and
marketing
of
medical
diagnostic
kits;
the
design,
manufacture
and
distribution
of
various
orthodontic
products;
the
performance
of
specialized
diagnostic
testing
services;
and
the
development
of
wireless
handheld
point-of-care
systems
for
physicians.
The
Company
conducts
these
businesses
through
three
subsidiaries,
Lancer
Orthodontics,
Inc.,
Allergy
Immuno
Technologies,
Inc.,
and
ReadyScript,
Inc.
Both
Lancer
and
AIT
are
majority-controlled
subsidiaries,
while
ReadyScript
is
a
wholly
owned
subsidiary
of
Biomerica.
The
Company
focuses
in
two
separate
areas,
its
diagnostic
business
and
its
proposed
point-of-care
wireless
handheld
technology
solutions.
The
Company
also
continues
to
develop
products
for
the
diagnostics
business. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Biomerica,
Inc.
develops,
manufactures
and
sells
medical
diagnostic
products
designed
to
detect
certain
medical
conditions
and
diseases
in
the
areas
of
certain
cancers,
heart
attack,
fertility
gastritis
and
ulcers,
diabetes
and
candida.
For
the
nine
months
ended
2/28/01,
net
sales
rose
16%
to
$6.5
million.
Net
loss
decreased
21%
to
$2
million.
Results
reflect
increased
sales
from
the
EZ
Detect
product,
along
with
decreased
S/G/A
expenses. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Zackary Irani, 34 Chairman,
Pres, CEO | $118K | $24K | Janet Moore, 49 Sec.,
Treasurer, Controller, Interim CFO, Director | -- | -- | Jagdish Sandhu, 49 Chief
Operating Officer of the Diagnostic | -- | -- | Dollar
amounts are as of 31-May-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|